1 min read

Chief Medical Officer Summit -CMO 360°

Meet the Veristat team at Booth #3, April 17th and 18th in Boston

The Science-First CRO™ and Consultancy Ready to Advance Your Revolutionary Therapy's Development, Approval, and Commercialization  

If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.

For 30 years, Veristat has helped pharmaceutical and biotech companies accelerate their clinical trials and commercialize their therapies by delivering Science-First solutions across the development lifecycle.  

We provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies.  


Don't miss this opportunity to connect with us at the Summit and learn more about how Veristat is making a difference in the lives of patients with rare and ultra-rare diseases. 

The Science-First CRO.™

Schedule A Meeting

Veristat team member, Erin Gaffney, Senior Business Development Director, will be at the venue, ready to listen to your needs and share Veristat’s expertise. Discover what makes Veristat a distinguished name in the clinical research industry. 


Arrange a meeting by completing the form on the right side of this page.  

Conference Details

Website: CMO Summit 360° ® 

 

Share This Event:

   

1 min read

Fierce Biotech Summit 2024

Meet Veristat in Boston at the Fierce Biotech Summit Conference | September 30 - October 1 in Boston, Massachusetts

We...

4 min read

Unique Challenges in Recruiting Patients for Rare Indication Pediatric Studies: Overcoming Difficulties through a Site and CRO Perspective

Don't miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Barcelona, Thursday, October 24th...